Diadenosine polyphosphates inhibit adenosine kinase activity but decrease levels of endogenous adenosine in rat brain

European Journal of Pharmacology

Volumn 332, Issue 1, 1997, Pages 35-42

  Delaney, Suzanne M ^a   Blackburn, G Michael ^b   Geiger, Jonathan D ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Adenine nucleotides; Adenosine; Brain; Diadenosine polyphosphate; Microwave; Rat

Indexed keywords

5' NUCLEOTIDASE; 9 (2 HYDROXY 3 NONYL)ADENINE; ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE DERIVATIVE; ADENOSINE KINASE; ADENOSINE MONOPHOSPHATE DEAMINASE; DIADENOSINE PENTAPHOSPHATE; DIADENOSINE POLYPHOSPHATE; DIADENOSINE TETRAPHOSPHATE; DIADENOSINE TRIPHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME INHIBITION; INTRACEREBRAL DRUG ADMINISTRATION; MALE; MICROINJECTION; MICROWAVE IRRADIATION; NONHUMAN; PRIORITY JOURNAL; RAT;

5'-NUCLEOTIDASE; ADENOSINE; ADENOSINE KINASE; AMP DEAMINASE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BRAIN CHEMISTRY; DINUCLEOSIDE PHOSPHATES; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RATS; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTOR AGENTS;

EID: 0030849928     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01057-1     Document Type: Article

References (46)

1. Delaney, S.M., Geiger, J.D., 1995. Enhancement of NMDA-induced increases in levels of endogenous adenosine by adenosine deaminase and adenosine transport inhibition in rat striatum. Brain Res. 702, 72-76.
2. Delaney, S.M., Geiger, J.D., 1996a. Brain regional levels of adenosine and adenosine nucleotides in rats killed by high-energy focused microwave irradiation. J. Neurosci. Methods 64, 151-156.
3. Delaney, S.M., Geiger, J.D., 1996b. N-methyl-D-aspartate-induced levels of endogenous adenosine are enhanced by inhibition of adenosine deaminase and adenosine transport. Soc. Neurosci. 25th Annual Meeting. San Diego, CA, USA, Nov., pp. 11-16.
4. Delicado, E.G., Casillas, T., Sen, R.P., Miras-Portugal, M.T., 1994. Evidence that adenine nucleotides modulate nucleoside-transporter function. Characterization of uridine transport in chromaffin cells and plasma membrane vesicles. Eur. J. Biochem. 225, 355-362.
5. Fernandez, A., Costas, M.J., Sillero, M.A.G., Sillero, A., 1984. Diadenosine tetraphosphate activates AMP deaminase from rat muscle. Biochem. Biophys. Res. Commun. 121, 155-161.
6. Geiger, J.D., Parkinson, F.E., Kowaluk, E.A., in press. Regulators of endogenous adenosine levels as therapeutic agents. In: Jacobson, K.A., Jarvis, M.F. (Eds.), Purinergic Approaches in Experimental Therapeutics. John Wiley and Sons, New York, NY.
7. Golembiowska, K., White, T.D., Sawynok, J., 1996. Adenosine kinase inhibitors augment release of adenosine from spinal cord slices. Eur. J. Pharmacol. 307, 157-162.
8. 3H]Adenosine, a new metabolically stable enantiomeric probe for adenosine transport systems in rat brain synaptoneurosomes. J. Neurochem. 56, 548-552.
9. Heymann, D., Reddington, M., Kreutzberg, G.W., 1984. Subcellular location of 5′-nucleotidase in rat brain. J. Neurochem. 43, 971-978.
10. Hoyle, C.H.V., 1990. Pharmacological activity of adenine dinucleotides in the periphery: Possible receptor classes and transmitter function. Gen. Pharmac. 21, 827-831.
11. 2X-purinoceptors and for purinergic transmission. Eur. J. Pharmacol. 174, 115-118.
12. 4-tetraphosphate and its related compounds. Int. J. Biochem. 22, 231-238.
13. Johnson, M.A., Fridland, A., 1989. Phosphorylation of 2′,3′-dideoxyinosine by cytosolic 5′-nucleotidase of human lymphoid cells. Mol. Pharmacol. 36, 291-295.
14. Jonzon, B., Fredholm, B.B., 1985. Release of purines, noradrenaline and GABA from rat hippocampal slices by field stimulation. J. Neurochem. 44, 217-224.
15. 2X purinoceptor transcripts in the rat nervous system. Mol. Pharmacol. 48, 569-573.
16. 2U-purinoceptor: Potent activation by diadenosine tetraphosphate. Br. J. Pharmacol. 116, 1619-1627.
17. Lloyd, H.G.E., Fredholm, B.B., 1995. Involvement of adenosine deaminase and adenosine kinase in regulating adenosine concentration in rat hippocampal slices. Neurochem. Int. 26, 387-395.
18. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurements with the folin phenol reagent. J. Biol. Chem. 193, 265-275.
19. Lutz, R.A., Bull, C., Rodbard, D., 1986. Computer analysis of enzyme- substrate-inhibitor kinetic data with automatic model selection using IBM-PC compatible microcomputers. Enzyme 36, 197-206.
20. + and veratridine. J. Neurochem. 45, 791-797.
21. 5A and α,β-methylene ATP on nonadrenergic, noncholinergic neurogenic excitation in the guinea-pig vas deferens. Br. J. Pharmacol. 94, 699-706.
22. 4A and Other Dinucleoside Polyphosphates. CRC Press, Boca Raton, FL, pp. 151-204.
23. McClennan, A.G., Taylor, G.E., Prescott, M., Blackburn, G.M., 1989. Recognition of ββ′-substituted and αβ,α′β′-disubstituted phosphonate analogues of bis(5′-adenosyl) tetraphosphate by the bis(5′-nucleosidyl)-tetraphosphate pyrophospohydrolases from Artemia embryos and Escherichia coli. Biochemistry 28, 3868-3875.
24. Mitchell, J.B., Lupica, C.R., Dunwiddie, T.V., 1993. Activity-dependent release of endogenous adenosine modulates synaptic responses in the rat hippocampus. J. Neurosci. 13, 3439-3447.
25. Orford, M., Mazurkiewicz, D., Saggerson, D., 1991. Soluble 5′-nucleotidase activities in rat brain. J. Neurochem. 56, 141-146.
26. Padua, R., Geiger, J.D., Dambock, S., Nagy, J.I., 1990. 2′-Deoxycoformycin inhibition of adenosine deaminase in rat brain: In vivo and in vitro analysis of specificity, potency and enzyme recovery. J. Neurochem. 54, 1169-1178.
27. Palmer, T.M., Stiles, G.L., 1995. Review: Neurotransmitter receptors VII. Adenosine receptors. Neuropharmacology 34, 683-694.
28. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, New York, NY.
29. xA) as new neurotransmitters. Drug Dev. Res. 28, 259-262.
30. 2 purinergic receptors for diadenosine polyphosphates in the nervous system. Gen. Pharmacol. 26, 229-235.
31. 2Y site. Br. J. Pharmacol. 103, 1980-1984.
32. 2 purinoceptors present on rat brain synaptic terminals. Br. J. Pharmacol. 108, 1094-1099.
33. 5A, from caudate putamen of conscious rat. Neurosci. Lett. 150, 13-16.
34. Pintor, J., Porras, A., Mora, F., Miras-Portugal, M.T., 1995. Dopamine receptor blockade inhibits the amphetamine-induced release of diadenosine polyphosphates, diadenosine tetraphosphate and diadenosine pentaphosphate, from the neostriatum of the conscious rat. J. Neurochem. 64, 670-676.
35. Ramos, A., Rotllan, P., 1995. Specific dinucleoside polyphosphate cleaving enzymes from chromaffin cells: A fluorimetric study. Biochim. Biophys. Acta 1253, 103-111.
36. 4A and Other Dinucleoside Polyphosphates. CRC Press, Boca Raton, FL, pp. 151-204.
37. nA, by bovine chromaffin cells in culture. Arch. Biochem. Biophys. 297, 176-183.
38. Rotllan, P., Miras-Portugal, M.T., 1985. Adenosine kinase from bovine adrenal medulla. Eur. J. Biochem. 151, 365-371.
39. 2Y agonists on adenosine transport in cultured chromaffin cells. J. Neurochem. 60, 613-619.
40. 4A and Other Dinucleoside Polyphosphates. CRC Press, Boca Raton, FL, pp. 205-228.
41. Van den Berghe, G., Bontemps, F., Vincent, M.F., Van den Berghe, F., 1992. The purine nucleotide cycle and its molecular defects. Prog. Neurobiol. 39, 547-561.
42. Van Wylen, D.G.L., Park, T.S., Rubio, R., Berne, R.M., 1986. Increases in cerebral interstitial fluid adenosine concentration during hypoxia, local potassium infusion, and ischemia. J. Cereb. Blood Flow Metab. 6, 522-528.
43. von Lubitz, D.K.J.E., Carter, M.F., Beenhakker, M., Lin, R.C.S., Jacobson, K.A., 1995. Adenosine: A prototherapeutic agent concept in neurodegeneration. Ann. N.Y. Acad. Sci. 765, 163-178.
44. Yamada, Y., Goto, H., Ogasawara, N., 1980. Purification and properties of adenosine kinase from rat brain. Biochim. Biophys. Acta 616, 199-207.
45. Zhang, G.E., Franklin, P.H., Murray, T.F., 1993. Manipulation of endogenous adenosine levels in the rat prepiriform cortex modulates seizure susceptibility. J. Pharmacol. Exp. Ther. 264, 1415-1424.
46. 2Y purinoceptors in the rat striatum. Brain Res. 691, 205-212.